Endocr Metab Immune Disord Drug Targets
March 2025
This mini-review aimed to present an outlook on childhood obesity and leukemia in different regions of Brazil and explore a possible association between biological aspects related to adipose tissue and childhood cancer. We emphasized environmental factors that may influence cancer development and obesity and present studies showing different prevalences of these diseases in Brazilian regions. However, future studies are required to determine how environmental factors in these regions contribute to leukemia and obesity development in childhood and adolescence.
View Article and Find Full Text PDFRev Port Cardiol
March 2025
In Portugal, a 15.2% prevalence of heart failure with preserved ejection fraction (HFpEF) was recently identified among those aged ≥50 years. HFpEF represents 90% of Portuguese heart failure patients.
View Article and Find Full Text PDFAims: Abdominal aortic aneurysm (AAA) is a life-threatening condition where inflammation plays a key role. Currently, AAA treatment relies exclusively on surgical interventions, and no guideline drug therapy to prevent aneurysm growth or rupture is available. Pharmacological reprogramming of immune cell metabolism, through the modulation of the pyruvate dehydrogenase kinase/pyruvate dehydrogenase (PDK/PDH) axis, has been identified as an attractive strategy to combat inflammation.
View Article and Find Full Text PDFBiomimetics (Basel)
January 2025
Biomaterials interact with biological systems, influencing their responses. Different types of polymers-both natural and synthetic-are widely used in biomedical engineering, among a plethora of healthcare applications, to promote tissue regeneration. The natural rubber latex extracted from is a biopolymer that whose biocompatibility makes it a valuable study object.
View Article and Find Full Text PDFFractional-dose inactivated poliovirus vaccine (fIPV), 1/5th of a standard IPV dose, is used in Cuba's routine immunization (RI) schedule. Tropis, a needle-free jet injector, simplifies intradermal fIPV administration and was piloted in Camagüey, Cuba, from 2019 to 2020. This study assessed Tropis' acceptability, safety, and immunogenicity compared to traditional needle and syringe (N/S) administration.
View Article and Find Full Text PDF